HLA Monomer Tetramer

NEWS

All
News

News

Four new easYmers®

27. July 2022

We are now adding HLA-A*02:06, HLA-B*38:01, HLA-B*44:03 and HLA-B*51:01 to our portfolio of loadable HLA molecules | easYmers® The peptide loadable MHC class I easYmer® portfolio represents, by far, the highest coverage of HLA allotypes across the regions of the world and ethnic groups. Exploitation of cellular immunity is important for future immunotherapies and general vaccine strategies (e.g covid-19) and

News

The Latest research..

31. August 2021

Where easYmer® monomers and Multimers have been used to describe SARS-CoV2 specific T cells and tumor specific neo-epitopes. 1. Oberhardt, V., et al., Rapid and stable mobilization of CD8(+) T cells by SARS-CoV-2 mRNA vaccine. Nature, 2021. 2. Sahin, U., et al., BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans. Nature, 2021. 3. Tippalagama, R., et al.,

News

Laborant proteinkemi

2. July 2021

Til en ny stilling inden for fremstilling af reagenser til immun monitorering søger vi en laborant der kan tiltræde snarest muligt. Om immunAware immunAware udvikler og producerer reagenser, som anvendes til identifikation og monitorering af antigen-specifikke T celler. Vores reagenser anvendes bl.a. til forskning indenfor immunterapi og vaccine udvikling af universiteter, biotek og pharma i hele verden. immunAware er en

News

PRESS RELEASE

21. June 2021

PRESS RELEASE IMMUDEX & IMMUNAWARE Hørsholm, 21 June 2021 Immudex and immunAware enter a partnership to boost the field of immune monitoring and single-cell multi-omics by expanding the availability of immunAware’s loadable MHC technology – easYmer®. Immudex and immunAware announce a business collaboration aimed at broadening the availability of immunAware’s easYmer® product portfolio through Immudex’ global sales channels and integrating the easYmer® monomers

News

New additions to the easYmer® portfolio

14. April 2021

We are now adding HLA-A26:01, HLA-A31:01 and HLA-A32:01 to our portfolio of loadable HLA molecules | easYmer® The easYmer® portfolio represents, by far, the highest coverage of HLA allotypes across the regions of the world and ethnic groups. Exploitation of cellular immunity is important for future immunotherapies and general vaccine strategies (e.g covid-19) and we strive to develop reagents which

News

Recent scientific papers using our reagents

6. July 2020

HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions. J Immunol. 2020;205(1):290-9. Specificity of CD8(+) T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya. Vaccines (Basel). 2020;8(2). Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus. Sci Rep. 2020;10(1):5851. In Silico Guided Discovery of Novel Class I and II Trypanosoma cruzi Epitopes Recognized by T

News

Immune monitoring COVID-19?

22. April 2020

Cells infected with SARS-CoV-2 are only visible to CD8+ T cell after virus proteins have been processed and presented by MHC class I molecules – and only then are the CD8+ T cell able to eradicate the infection. While antibodies against virus are important to prevent or minimise infection, CD8+ T cells are responsible for clearing the virus from the

News

Meet us at PEGS2020

4. March 2020

Come talk to us about immune monitoring and epitope discovery in Boston May 4-8. Leave us a note below if you wish to arrange a meeting.

News

More MHC molecules added

21. August 2019

We have added HLA-A*11:01, HLA-B*44:02 and HLA-C*07:02 to our list of peptide receptive DIY MHC easYmers® bringing our list of “empty” MHC molecules up to 31 allotypes. Our easYmers allow you to make mono- and tetramers from day-to-day in your own lab without any special expertise or equipment. We have also added HLA-A*02:01(ELAGIGILTV) MelanA and HLA-DRB5*01:01 (NIEFFTKNSAFPKTT) IE1

News

MHC Monomers – new peptide receptive molecules added

19. June 2019

Our comprehensive list of MHC allotypes formulated as peptide receptive molecules continues to grow. We recently added HLA-A*24:02, A*29:02, A*68:02, B*08:01, B*15:01, B*15:02, B*46:01 and B*57:02 to the list of our peptide receptive MHC monomers – we call them easYmers®. Naturally, you will also find the more commonly used HLA-A*02:01, A*01:01 and B*07:02 on our product list of peptide loadable

News

Meet us at AACR 2019

20. March 2019

Are you interested in learning more about how you can make your own MHC monomers and tetramers from day-to-day in your own lab? Then come see us at AACR19 | Booth#4644 where we will be explaining our easYmer® technology. The easYmer® will speed up your work with neo-antigen specific T cells

News

immunAware is a spin-out company from the University of Copenhagen

1. June 2018

immunAware is a spin-out company from the University of Copenhagen, which offers a large and growing portfolio of MHC class I and II molecules. We recently introduced a formulation of empty MHC class I molecules, easYmers, which allows non-expert end-user to generate HLA mono and tetramers with any peptide binder of interest; no biochemical expertise or equipment is needed. With

Visit our LinkedIn company profile to Follow Us!

We post new HLA monomer and Tetramer additions to our catalog - updates on papers focusing on the use of HLA Tetramers in cell therapy, immuno oncology, vaccine etc.